J.H. Whitney Equity Partners V Sells 2,419,035 Shares of Aveanna Healthcare (NASDAQ:AVAH) Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder J.H. Whitney Equity Partners V sold 2,419,035 shares of the business’s stock in a transaction on Tuesday, June 30th. The stock was sold at an average price of $8.01, for a total value of $19,376,470.35. Following the completion of the transaction, the insider owned 10,112,123 shares of the company’s stock, valued at $80,998,105.23. This represents a 19.30% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

J.H. Whitney Equity Partners V also recently made the following trade(s):

• On Wednesday, June 24th, J.H. Whitney Equity Partners V sold 919,389 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.00, for a total value of $7,355,112.00.
• On Wednesday, June 3rd, J.H. Whitney Equity Partners V sold 5,842,240 shares of Aveanna Healthcare stock. The stock was sold at an average price of $6.24, for a total value of $36,455,577.60.

Aveanna Healthcare Price Performance

NASDAQ AVAH opened at $9.10 on Friday. Aveanna Healthcare Holdings Inc. has a one year low of $3.73 and a one year high of $10.32. The stock has a 50-day moving average of $7.36 and a 200 day moving average of $7.57. The company has a debt-to-equity ratio of 5.35, a quick ratio of 1.47 and a current ratio of 1.47. The company has a market capitalization of $1.98 billion, a price-to-earnings ratio of 7.71, a PEG ratio of 0.94 and a beta of 1.89.

Aveanna Healthcare (NASDAQ:AVAH) last posted its earnings results on Thursday, May 14th. The company reported $0.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.13 by $0.05. The business had revenue of $647.91 million for the quarter, compared to analysts’ expectations of $613.22 million. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. The business’s quarterly revenue was up 15.9% compared to the same quarter last year. On average, sell-side analysts forecast that Aveanna Healthcare Holdings Inc. will post 0.65 EPS for the current year.

Hedge Funds Weigh In On Aveanna Healthcare

Several institutional investors have recently made changes to their positions in the business. Caitong International Asset Management Co. Ltd boosted its holdings in shares of Aveanna Healthcare by 252.4% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after buying an additional 2,400 shares during the last quarter. Summit Securities Group LLC bought a new stake in Aveanna Healthcare during the first quarter valued at approximately $53,000. Quantbot Technologies LP bought a new stake in Aveanna Healthcare during the second quarter valued at approximately $43,000. EverSource Wealth Advisors LLC increased its holdings in Aveanna Healthcare by 88,100.0% during the third quarter. EverSource Wealth Advisors LLC now owns 11,466 shares of the company’s stock valued at $102,000 after buying an additional 11,453 shares during the last quarter. Finally, Entropy Technologies LP purchased a new stake in Aveanna Healthcare during the third quarter valued at approximately $107,000. Institutional investors own 87.96% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently weighed in on AVAH shares. Royal Bank Of Canada upgraded shares of Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 price objective on the stock in a research report on Wednesday, June 3rd. Barclays cut their target price on shares of Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating for the company in a research report on Monday, May 18th. Stephens upgraded shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $10.00 to $11.00 in a research note on Friday, May 15th. Truist Financial increased their price target on Aveanna Healthcare from $8.00 to $9.00 and gave the company a “hold” rating in a report on Wednesday, May 20th. Finally, Raymond James Financial upgraded Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price target on the stock in a research note on Friday, March 20th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $10.50.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.